Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Berry

Showing results (571-580 of 698) with videos related to

Pageof 70
Sort By:
Journal of the Royal Society of Medicine|November 14, 2022
Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort studyMehrdad A Mizani, Ashkan Dashtban, Laura Pasea, et al.
European Heart Journal|July 7, 2020
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study GroupVijay Kunadian, Alaide Chieffo, Paolo G Camici, et al.
Circulation|October 5, 2023
Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled TrialNovalia P Sidik, Bethany Stanley, Robert Sykes, et al.
Journal of the American College of Cardiology|May 16, 2024
Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial InfarctionRob Eerdekens, Mohamed El Farissi, Giovanni Luigi De Maria, et al.
Archives of Toxicology|August 7, 2021
The EU chemicals strategy for sustainability: in support of the BfR positionFrank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
The New England Journal of Medicine|June 20, 2019
Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary DiseaseEike Nagel, John P Greenwood, Gerry P McCann, et al.
Circulation. Cardiovascular Interventions|March 28, 2023
Angina After Percutaneous Coronary Intervention: Patient and Procedural PredictorsDamien Collison, Samuel Copt, Takuya Mizukami, et al.
ESC Heart Failure|May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and designJaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Circulation. Cardiovascular Interventions|February 16, 2021
Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial InfarctionAnnette M Maznyczka, Peter J McCartney, Keith G Oldroyd, et al.
Circulation. Cardiovascular Quality and Outcomes|February 16, 2018
High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina PectorisPhilip D Adamson, Amanda Hunter, Debbie M Madsen, et al.
Pageof 70

Showing results (571-580 of 698) with videos related to

Sort By:
Pageof 70
Journal of the Royal Society of Medicine|November 14, 2022
Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort studyMehrdad A Mizani, Ashkan Dashtban, Laura Pasea, et al.
European Heart Journal|July 7, 2020
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study GroupVijay Kunadian, Alaide Chieffo, Paolo G Camici, et al.
Circulation|October 5, 2023
Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled TrialNovalia P Sidik, Bethany Stanley, Robert Sykes, et al.
Journal of the American College of Cardiology|May 16, 2024
Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial InfarctionRob Eerdekens, Mohamed El Farissi, Giovanni Luigi De Maria, et al.
Archives of Toxicology|August 7, 2021
The EU chemicals strategy for sustainability: in support of the BfR positionFrank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
The New England Journal of Medicine|June 20, 2019
Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary DiseaseEike Nagel, John P Greenwood, Gerry P McCann, et al.
Circulation. Cardiovascular Interventions|March 28, 2023
Angina After Percutaneous Coronary Intervention: Patient and Procedural PredictorsDamien Collison, Samuel Copt, Takuya Mizukami, et al.
ESC Heart Failure|May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and designJaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Circulation. Cardiovascular Interventions|February 16, 2021
Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial InfarctionAnnette M Maznyczka, Peter J McCartney, Keith G Oldroyd, et al.
Circulation. Cardiovascular Quality and Outcomes|February 16, 2018
High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina PectorisPhilip D Adamson, Amanda Hunter, Debbie M Madsen, et al.
Pageof 70